IL-8, IL-10, TGF-𝜷, and GCSF Levels Were Increased in Severe Persistent Allergic Asthma Patients with the Anti-IgE Treatment

Figure 3

TGF-β levels of severe persistent asthma patients before and 4 months after the anti-IgE therapy (𝑃=0.013).